乐观
$36.73
情景价格
$28.190
+0.031 (+0.11%)收盘时
Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu.
Celsius Holdings Inc is not a strong buy right now. The current price is $28.19, which is significantly below the analyst price targets of $42 and $45. However, the stock has experienced a year-to-date decline of 40.96%, indicating potential value but also significant risk. The RSI is at 56.165, suggesting the stock is neither overbought nor oversold. The main risk is the recent downgrade by Deutsche Bank, which cites fundamental challenges and a lack of confidence in a quick recovery, with a price target of $35.
Morgan Stanley
$42
2026-09-17
Morgan Stanley
2026-09-17
目标价
$42
Deutsche Bank
$35
2026-08-27
Deutsche Bank
2026-08-27
目标价
$35
Goldman Sachs
$45
2026-08-10
Goldman Sachs
2026-08-10
目标价
$45
Stephens
$50
2026-08-10
Stephens
2026-08-10
目标价
$50
Morgan Stanley
$42
2026-08-07
Morgan Stanley
2026-08-07
目标价
$42
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Celsius Holdings Class Action Notice Issued

Celsius Holdings Class Action Reminder

Celsius Holdings Class Action Lawsuit Announcement

Analysis of Monster Beverage's Competitive Advantages

Monster Beverage's Unique Debt-Free Advantage
Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu. It operates in the Consumer Non-Cyclicals sector (BOTTLED & CANNED SOFT DRINKS & CARBONATED WATERS industry).
Celsius Holdings Inc is not a strong buy right now. The current price is $28.19, which is significantly below the analyst price targets of $42 and $45. However, the stock has experienced a year-to-date decline of 40.96%, indicating potential value but also significant risk. The RSI is at 56.165, suggesting the stock is neither overbought nor oversold. The main risk is the recent downgrade by Deutsche Bank, which cites fundamental challenges and a lack of confidence in a quick recovery, with a price target of $35.
1 analysts cover CELH: 1 rate it Buy, 0 Hold and 0 Sell. The average price target is 62.85.

$CELH looks like it's finally starting to curl off long-term support here. There's a lot of room to drift up from here within this triangle ⤴️ The 50 WMA is $36.73.
展开
$CELH could realistically consolidate until June 2027. It has about 8 months of room left before it reaches the apex of this massive symmetrical triangle, before it could break out and start the next bull run or leg up. Not financial advice, just food for thought. Shares are probably the best way to go to avoid theta decay.
展开
$CELH below $30 isn't an attractive short. It's a $100 stock with a good COO.
展开
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。